The Conference Forum has been acquired by Questex LLC, the parent company of Fierce Healthcare & Life Sciences.
Editorial by Category
Modernizing Clinical Trial Operations
View All
End-to-End Innovation: How Technology is Transforming Every Step of the Clinical Trial Value Stream
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
Conference Forum Joins Fierce Life Sciences
The Trifecta of Protocol Review: Patients, Sites, and Sponsors Building Better Studies
Immuno-Oncology and Cell Therapy
View All
Drug Delivery
View All
Conference Forum Joins Fierce Life Sciences
Implementing a Control Strategy for Combination Product Design and Manufacturing
Partnering for Combination Product Success: Higher-Level Collaboration that Delivers Higher ROI
Overcoming the Limitations of PLGA-Based Technologies to Enable Better Long-Acting Injectables
Patients as Partners in Clinical Research and Patient Access
View All
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
How Sponsors Can Be Better Partners to Rural Sites Bringing Clinical Research to Patients
Conference Forum Joins Fierce Life Sciences
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Biotech CMO/R&D Leadership
View All
Community-Based Clinical Trials
View All
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
Conference Forum Joins Fierce Life Sciences
Building an Infrastructure to Drive More Effective Patient Enrollment and Retention: Partnerships with Sites Summit 2025 Recap
How AbbVie Is Shifting the Focus from Decentralization to Patient & Site Centricity
Women Leadership in Biotech
View All
Commercializing Therapies Requires Patient-Centricity and Advocacy
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
How Sponsors Can Help Sites with Payment, Staffing and Technology
